Six clinically isolated strains of Serratia marcescens were tested for their drug resistance. All showed fairly high resistance to many antimicrobial agents tested including norfloxacin, streptomycin, ampicillin, erythromycin, tetracycline, chloramphenicol, and antimicrobial dyes. Using the drug-hypersensitive strain of Escherichia coli KAM32 as the host, we cloned the genes responsible for multidrug resistance from chromosomal DNA of one of the strains of S. marcescens, NUSM8906. We obtained 28 hybrid plasmids that made host cells resistant to several antimicrobial agents. Many of the transformants harboring each of the plasmids showed multidrug resistance, and some showed resistance to specific drugs. The hybrid plasmids were classified into several groups based on their drug specificity. It appears that each class of plasmid carries different types of drug resistance genes. Analysis of such genes will reveal the multiple mechanisms involved in multidrug resistance in S. marcescens.
The discovery and synthesis of antimicrobial agents are extremely valuable for human beings in the treatment of infectious diseases. Many infectious diseases once considered incurable became curable due to antimicrobial agents, including antibiotics such as penicillin, streptomycin, erythromycin, etc. However, the emergence and spread of drug resistance in bacteria, and its association with serious infectious diseases, have recently increased. 1) Thus it is becoming difficult to treat infectious diseases caused by drug-resistant bacteria.
2) An extremely serious problem with drug-resistant bacteria is the emergence and spread of multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). As implied by the term "multidrug resistance", many antimicrobial agents are not effective against MRSA and VRE, and hence it is very difficult to treat infections due to such multidrug-resistant bacteria.
There are many genes for drug resistance in bacterial genomes, and in extra chromosomal DNA, which are responsible for different mechanisms of drug resistance such as drug efflux pumps, enzymes that inactivate drugs, and alteration in targets of drugs.
3) An extensive knowledge of molecular mechanisms underlying bacterial drug resistance, especially multidrug resistance, is required to control multidrug resistant bacteria and to treat patients infected with multidrug-resistant bacteria successfully.
Serratia marcescens is now becoming an important cause of hospital-acquired infections. It has been reported that S. marcescens is associated with respiratory tract infections, urinary tract infections, septicemia, meningitis, and wound infections. 4) Infections by S. marcescens and patient deaths are sometimes reported in newspapers. Two patients in Gunma and three patients in Tokyo died of S. marcescens infection in hospitals in 2002 in Japan. A serious problem in the treatment of patients infected with S. marcescens is that this organism shows intrinsic resistance to a wide variety of antimicrobial agents (multidrug resistance). 4) It is important to investigate the mechanisms by which S. marcescens acquires multidrug resistance. Gene cloning, expression, and biochemical analysis of drug-resistance systems are valuable approaches to the understanding of the mechanism of multidrug resistance.
In this study, we report patterns of drug resistance in six clinically isolated strains of S. marcescens and functional gene cloning of the drug-resistance systems.
MATERIALS AND METHODS

Bacteria and Growth
Clinically isolated S. marcescens strains NUSM8901, NUSM8902, NUSM8903, NUSM8904, NUSM8905, and NUSM8906 were used in this study. These strains were a generous gift from Dr. Y. Arakawa of the National Institute of Infectious Diseases, Japan. Escherichia coli KAM32, E. coli TG1, and Pseudomonas aeruginosa PAO1 were also used. E. coli KAM32, a derivative of TG1, lacks the major multidrug efflux pump AcrAB and shows hypersensitivity to many antimicrobial agents 5) and is useful as a host for gene cloning of drug-resistance systems. Cells were grown in L medium 6) at 37°C. Drug Susceptibility Test The minimal inhibitory concentrations (MICs) of various drugs were determined in Muller-Hinton broth (Difco) using the standard two-fold dilution method. 7) Bacterial cells (about 10 5 cells) were inoculated and incubated in the test medium (5 ml) at 37°C for 20 h and the growth was examined by visual inspection.
Gene Cloning Chromosomal DNA was prepared from cells of S. marcescens NUSM8906 by the method of Berns and Thomas.
8) The DNA was partially digested with Sau3AI and the fragments from 4 to 10 k-base pairs (bp) were separated by sucrose-density gradient centrifugation. Plasmid DNA of pBR322 (middle-copy plasmid) or pSTV28 (lowcopy plasmid) was digested with BamHI, dephosphorylated with bacterial alkaline phosphatase and then ligated to the chromosomal DNA fragments using a ligation kit, Ver. 2 (TaKaRa Co.). Competent cells 9) of E. coli KAM32 were transformed with the recombinant plasmids and spread on agar (1.5%) plates containing L broth, ampicillin 60 mg/ml, and one of the following drugs: erythromycin (10 mg/ml), tetracycline (4 mg/ml), norfloxacin (0.05 mg/ml), ethidium bromide (10 mg/ml), 4Ј,6-diamidino-2-phenylindole (DAPI) (0.5 mg/ml) or chloramphenicol (20 mg/ml). The plates were incubated at 37°C for 24 h. We obtained 28 candidate colonies on the plates. Each candidate colony was purified by single colony isolation on the plate containing each drug. Plasmids were isolated from each of the candidates. Plasmid DNAs were retransformed in the KAM32 cells, spread on the same type of plate, and their resistance against various antimicrobial agents tested. We confirmed that one type of plasmid was harbored in each candidate clone by the retransformation and by checking the restriction fragment of each plasmid. All hybrid plasmids carried DNA inserts of 3.0 to 10.5 kbp. (10 mg/ml) (4 mg/ml) (10 mg/ml) (0.5 mg/ml) (2 mg/ml) (2 mg/ml)
RESULTS AND DISCUSSION
Nor, norfloxacin; EM, erythromycin; Tet, tetracycline; EtBr, ethidium bromide; DAPI, 4Ј,6-diamidino-2-phenylindole; KM, kanamycin; CP, chloramphenicol. ϩ, cells grew. Ϫ, cells did not grow.
that showed intrinsic resistance to many antimicrobial agents. The MICs of chloramphenicol in all S. marcescens strains tested were higher than the MICs in P. aeruginosa PAO1. Thus it is clear that the six clinically isolated strains of S. marcescens are resistant to many antimicrobial agents, and the level of resistance is similar to or higher than that in P. aeruginosa, a well-known multidrug resistant bacterium.
Functional Cloning of Genes for Drug Resistance and Classification We tried to clone S. marcescens NUSM8906 genes responsible for drug resistance using E. coli KAM32, a drug hyper-sensitive strain, as the host. We obtained 28 candidate clones harboring recombinant plasmids using several antimicrobial agents for the selection of drug-resistant clones. One clone was obtained from the erythromycin plate, one clone from the tetracycline plate, three clones from the norfloxacin plate, seven clones from the ethidium bromide plate, eight clones from the DAPI plate, and eight clones from the chloramphenicol plate (Table 2 ). They showed different patterns of drug resistance. The clone obtained from the erythromycin plate showed resistance not only to erythromycin but also to norfloxacin, tetracycline, ethidium bromide, DAPI, and kanamycin. The clone obtained from the tetracycline plate showed resistance only to tetracycline among the antimicrobial agents tested. The three clones obtained from the norfloxacin plate showed resistance not only to norfloxacin but also to DAPI. The eight clones obtained from the DAPI plate showed resistance not only to DAPI but also to norfloxacin and tetracycline. One clone obtained from the chloramphenicol plate showed resistance not only to chloramphenicol but also to tetracycline, and another showed resistance only to chloramphenicol. Drug resistance patterns among clones obtained from the ethidium bromide plate were versatile and classified into four types. The first type (four clones) showed resistance to erythromycin, tetracycline, norfloxacin, kanamycin, DAPI, and ethidium bromide. The second type was resistant to erythromycin, tetracycline, kanamycin, DAPI and ethidium bromide. The third type was resistant to tetracycline, norfloxacin, kanamycin, DAPI, and ethidium bromide. The fourth type showed resistance to DAPI and ethidium bromide. Thus the 28 clones were classified into nine types based on their drug specificity. We checked the restriction fragments of each plasmid and confirmed that plasmids that conferred the same drug specificity possessed a common DNA fragment. Thus it appears that we cloned nine different types of drug resistance gene(s). Among them, one type was specific to tetracycline, and another type was specific to chloramphenicol. Others were resistant to multiple structurally unrelated antimicrobial agents. Those seven types may represent multidrug efflux pumps, because only the multidrug efflux pump is involved in all multidrug resistance among known drug-resistance mechanisms. It should be noted that the vector plasmid pSTV28 carries the gene for chloramphenicol resistance. Thus we did not check chloramphenicol resistance with candidate hybrid plasmids derived from pSTV28 (Table 2) .
In E. coli or P. aeruginosa, in which the existence of more than 30 multidrug efflux pumps is suggested from their genome sequences, it is clear that multidrug efflux pumps are mainly involved in intrinsic and acquired multidrug resistance. Although we do not know at present how many systems of drug resistance are present in S. marcescens, it appears that cloned genes of S. marcescens contribute to the observed multidrug resistance of this microorganism. Genetic analysis of the cloned genes and biochemical analysis of the gene products are now in progress.
